PEPTIDE MANUFACTURING · OEM · PRIVATE LABELFOR RESEARCH BRANDS & DISTRIBUTORS
Back to catalogue
Synova Liraglutide representative vial artwork — 10 mg
Representative Synova artwork · 10 mg shown.
Final label and container are confirmed for your order.

Metabolic & Weight Management Research

Liraglutide

Vial presentation

>99% Purity · specification

Define the quantity, presentation and documentation your programme requires. We confirm the final specification before production.

BUILD YOUR PRODUCT BRIEF

Final fill, concentration, container and format compatibility are confirmed for your programme.

PROFESSIONAL RESEARCH

For laboratory research only. Not for human or veterinary use.

SUPPLY REFERENCE

Liraglutide specifications

Use these reference specifications to define your B2B enquiry. Include your target quantity, destination and any OEM or documentation requirements. Final formulation, compatibility, availability and minimum quantities are confirmed for your programme.

Review the quality and documentation route
Liraglutide reference specifications
FormatSpecification
Vial10 mg

QUALITY & BATCH DOCUMENTATION

>99% Purity

General peptide purity specification. The batch-specific laboratory report records the tested sample, method and measured result.

Request batch documentation

Independent batch testing included

Every order includes the additional testing box, random selection at the shipper and shipment hold. SYNOVA authorizes release only after reviewing and accepting the laboratory result.

Batch-specific CoA and analytical documentation: request availability for your order.

Optional, additional fee: a customer- or brand-name report with QR and verification codes.